122 Results

People

  1. Tuttle
    Tuttle
  2. Larson
    Larson
  3. Schoder
    Schoder
  4. Grewal
    Grewal
  5. Fagin
    Fagin
  6. Ho
    Ho
  7. Ghossein
    Ghossein
  8. Fox
    Fox
  9. Haque
    Haque
  10. Sherman
    Sherman

Groups

  1. Department of Medicine (122)
  2. Division of Subspecialty Medicine (122)
  3. Molecular Imaging and Therapy Service (122)
  4. Radiology, Department of (118)
  5. Survivorship Research (92)
  6. GSK Faculty (84)
  7. Endocrinology (71)
  8. Molecular Pharmacology and Chemistry Program Faculty (67)
  9. Sloan Kettering Institute Faculty (67)
  10. Solid Tumor Oncology Division (44)
  1. "Division of Subspecialty Medicine "
  2. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (87)
  2. Meeting Abstract (29)
  3. Book Section (4)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Department of Medicine (122)
  2. Division of Subspecialty Medicine (122)
  3. Molecular Imaging and Therapy Service (122)
  4. Radiology, Department of (118)
  5. Survivorship Research (92)
  6. GSK Faculty (84)

More Groups

People
  1. Steven Larson (63)
  2. Robert Tuttle (51)
  3. Ravinder Grewal (38)
  4. Heiko Schoder (30)
  5. Ronald Ghossein (22)
  6. James Fagin (19)

More People

Years
  1. 2024 (1)
  2. 2023 (6)
  3. 2022 (5)
  4. 2021 (7)
  5. 2020 (8)
  6. 2019 (11)

More Years

Publications
  1. Journal of Nuclear Medicine (18)
  2. Thyroid (11)
  3. Journal of Clinical Oncology (9)
  4. Journal of Clinical Endocrinology and Metabolism (8)
  5. Blood (7)
  6. European Journal of Nuclear Medicine and Molecular Imaging (6)

More Publications

Publishers
  1. Society of Nuclear Medicine (18)
  2. Springer (17)
  3. Mary Ann Liebert, Inc (11)
  4. Oxford University Press (10)
  5. American Society of Clinical Oncology (9)
  6. American Society of Hematology (7)

More Publishers

Results (122)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: Overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs
    Editorial

    Bodei, L.; Tuttle, R. M.; Grewal, R. K.; Mauguen, A.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J. R.; Haque, S.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Prospective comparison of F-18-TFB and I-124 PET/CT in metastatic thyroid cancer
    Meeting Abstract

    Backhaus, P.; Pentlow, K.; Ho, A.; Mauguen, A.; Fagin, J.; Pillarsetty, N. V. K.; Lyashchenko, S.; Abusamra, M.; Larson, S.; Schoder, H.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Prospective comparison of F-18-TFB and I-124 PET/CT in metastatic thyroid cancer
    Meeting Abstract

    Backhaus, P.; Pentlow, K.; Ho, A. L.; Mauguen, A.; Fagin, J. A.; Pillarsetty, N. V. K.; Lyashchenko, S. K.; Burnazi, E.; Ghossein, R. A.; Chhabra, S.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Patient metabolic profiles defined by liver and muscle 18F-FDG PET avidity are independently associated with overall survival in gastric cancer
    Meeting Abstract

    Vitiello, G. A.; Jayaprakasam, V. S.; Tang, L.; Schattner, M.; Janjigian, Y.; Ku, G.; Maron, S.; Schoder, H.; Larson, S.; Gonen, M.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): A regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
    Journal Article

    Mauguen, A.; Grewal, R. K.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J.; Haque, S.; Wong, B. Z. Y.; Ghossein, R. A.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Long-term prognostic value of (82)Rb PET/CT-determined myocardial perfusion and flow reserve in cancer patients
    Journal Article

    Fox, J. J.; Mauguen, A.; Ito, K.; Gupta, D.; Yu, A.; Schindler, T. H.; Strauss, H. W.; Schòˆder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Genomic and transcriptomic characteristics of metastatic thyroid cancers with exceptional responses to radioactive iodine therapy
    Journal Article

    Boucai, L.; Saqcena, M.; Kuo, F.; Grewal, R. K.; Socci, N.; Knauf, J. A.; Krishnamoorthy, G. P.; Ryder, M.; Ho, A. L.; Ghossein, R. A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinicopathologic and prognostic features of pediatric follicular cell-derived thyroid carcinomas: A retrospective study of 222 patients
    Journal Article

    Saliba, M.; Alzumaili, B. A.; Katabi, N.; Dogan, S.; Tuttle, R. M.; Zoltan, A.; Pandit-Taskar, N.; Xu, B.; Ghossein, R. A.
    American Journal of Surgical Pathology (2022)

    Fulltext@MSK | Save
  • Associations of body fat distribution and cardiometabolic risk of testicular cancer survivors after cisplatin-based chemotherapy
    Journal Article

    Wibmer, A. G.; Dinh, P. C. Jr; Travis, L. B.; Chen, C.; Bromberg, M.; Zheng, J.; Capanu, M.; Sesso, H. D.; Feldman, D. R.; Vargas, H. A.
    JNCI Cancer Spectrum (2022)

    Fulltext@MSK | Save